Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Intangibles (2021 - 2025)

Historic Intangibles for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $15.5 million.

  • Kiniksa Pharmaceuticals International's Intangibles fell 606.06% to $15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.5 million, marking a year-over-year decrease of 606.06%. This contributed to the annual value of $16.2 million for FY2024, which is 1875.0% down from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Intangibles stood at $15.5 million for Q3 2025, which was down 606.06% from $15.8 million recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Intangibles high stood at $20.0 million for Q1 2021, and its period low was $15.5 million during Q3 2025.
  • For the 5-year period, Kiniksa Pharmaceuticals International's Intangibles averaged around $18.5 million, with its median value being $20.0 million (2021).
  • In the last 5 years, Kiniksa Pharmaceuticals International's Intangibles changed by 0.0% in 2022 and then tumbled by 1875.0% in 2024.
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Intangibles stood at $20.0 million in 2021, then changed by 0.0% to $20.0 million in 2022, then changed by 0.0% to $20.0 million in 2023, then fell by 18.75% to $16.2 million in 2024, then dropped by 4.62% to $15.5 million in 2025.
  • Its Intangibles was $15.5 million in Q3 2025, compared to $15.8 million in Q2 2025 and $16.0 million in Q1 2025.